We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company for Carboprost Tromethamine Injection USP 250 mcg/mL.
26-May-2023
Download PDF
Aurobindo Pharma
We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company for Carboprost Tromethamine Injection USP 250 mcg/mL.
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds